Genomic Landscape of Chromosome X Factor VIII
Author Information
Author(s): Morris Olivia, Morris Michele, Jobe Shawn, Bhargava Disha, Krueger Jena M., Arora Sanjana, Prokop Jeremy W., Stenger Cynthia
Primary Institution: University of North Alabama
Hypothesis
How do variants in the F8 gene affect hemophilia A in males and risk variants in females?
Conclusion
The study emphasizes the need to better define missense variants in the F8 gene, particularly for variants of uncertain significance and those from non-European populations.
Supporting Evidence
- Variants within factor VIII (F8) are linked to hemophilia A and thrombosis.
- Many F8 variants remain variants of uncertain significance (VUS).
- Gene therapy approaches are available for pathogenic variants.
- Missense variants in F8 show significant variability in expression across populations.
- Female carriers of F8 variants can exhibit variable phenotypes.
- Recent FDA approval of gene therapy for hemophilia A highlights the need for better genetic understanding.
- Population-specific allele frequencies for F8 variants indicate a need for diverse genomic studies.
Takeaway
This study looks at how changes in a specific gene related to blood clotting can affect both men and women differently, especially in cases of hemophilia.
Methodology
Data on F8 expression was assessed while screening multiple genomic databases for F8 missense variants.
Potential Biases
There is a significant stratification of potential annotation issues for missense variants in subjects of non-European ancestry.
Limitations
The study highlights the lack of confident phenotyping data for female carriers of known pathogenic variants.
Participant Demographics
The study includes data from diverse populations, particularly focusing on non-European ancestry.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website